| scholarly article | Q13442814 |
| P50 | author | Michael P. Diamond | Q38804515 |
| D. Randall Armant | Q42657516 | ||
| P2093 | author name string | Jing Dai | |
| Alan D Bolnick | |||
| Brian A Kilburn | |||
| Michael Hertz | |||
| Jay M Bolnick | |||
| Manvinder Singh | |||
| P2860 | cites work | In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies | Q28350804 |
| STRIDER: Sildenafil Therapy In Dismal prognosis Early-onset intrauterine growth Restriction--a protocol for a systematic review with individual participant data and aggregate data meta-analysis and trial sequential analysis | Q30775123 | ||
| Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: the Boyd collection revisited | Q33732595 | ||
| Nitric oxide dysfunction in the pathophysiology of preeclampsia | Q34004873 | ||
| The nitric oxide pathway and possible therapeutic options in pre-eclampsia | Q34065261 | ||
| cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action | Q34244951 | ||
| Diagnosis and management of pre-eclampsia: an update | Q34345684 | ||
| Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. | Q34401845 | ||
| Endometrial growth and uterine blood flow: a pilot study for improving endometrial thickness in the patients with a thin endometrium | Q34939739 | ||
| Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure | Q35829649 | ||
| Placental oxidative stress: from miscarriage to preeclampsia | Q35879133 | ||
| Preeclampsia: recent insights | Q36288757 | ||
| Roles of nitric oxide and asymmetric dimethylarginine in pregnancy and fetal programming | Q36432504 | ||
| Diminished survival of human cytotrophoblast cells exposed to hypoxia/reoxygenation injury and associated reduction of heparin-binding epidermal growth factor-like growth factor. | Q36666688 | ||
| Hypoxia and reoxygenation: a possible mechanism for placental oxidative stress in preeclampsia | Q36686796 | ||
| Effects and mechanisms of action of sildenafil citrate in human chorionic arteries. | Q37187656 | ||
| Mechanisms and potential therapies for preeclampsia | Q37211008 | ||
| Sildenafil-mediated neovascularization and protection against myocardial ischaemia reperfusion injury in rats: role of VEGF/angiopoietin-1 | Q37310691 | ||
| Sildenafil attenuates placental ischemia-induced hypertension | Q37323529 | ||
| Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia | Q37350668 | ||
| Defective deep placentation | Q37812517 | ||
| Molecular cloning and expression of human cGMP-binding cGMP-specific phosphodiesterase (PDE5). | Q38336160 | ||
| Evidence of synergistic/additive effects of sildenafil and erythropoietin in enhancing survival and migration of hypoxic endothelial cells. | Q39234023 | ||
| Extracellular matrix composition and hypoxia regulate the expression of HLA-G and integrins in a human trophoblast cell line. | Q40898779 | ||
| Sildenafil for the treatment of preeclampsia | Q43109528 | ||
| Sildenafil decreased cardiac cell apoptosis in diabetic mice: reduction of oxidative stress as a possible mechanism. | Q43273844 | ||
| Sildenafil citrate therapy for severe early-onset intrauterine growth restriction. | Q43639662 | ||
| Expression of vascular endothelial growth factor (VEGF) and its receptors in human endometrium throughout the menstrual cycle and in early pregnancy | Q43907829 | ||
| Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. | Q44044678 | ||
| Endothelial dysfunction in the human umbilical artery due to preeclampsia can be prevented by sildenafil | Q44308542 | ||
| Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension | Q44471394 | ||
| Effects of a phosphodiesterase-5 (PDE5) inhibitor on endothelium-dependent relaxation of myometrial small arteries | Q44914088 | ||
| Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis | Q46058843 | ||
| Sildenafil citrate decreases sFlt-1 and sEng in pregnant l-NAME treated Sprague-Dawley rats | Q46298778 | ||
| Expression of phosphodiesterase 5 in maternal and fetal sheep | Q46698469 | ||
| Pathophysiologic features of "thin" endometrium | Q46712309 | ||
| PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries | Q46782881 | ||
| Circulating angiogenic factors and the risk of preeclampsia | Q47217679 | ||
| Effects of sildenafil and tadalafil on ischemia/reperfusion injury in fetal rat brain | Q48169431 | ||
| Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. | Q53600812 | ||
| Placental stress and pre-eclampsia: a revised view. | Q54774592 | ||
| Pre-eclampsia | Q56019568 | ||
| Loss of endothelium-dependent relaxation in myometrial resistance arteries in pre-eclampsia | Q59367714 | ||
| Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants | Q69685000 | ||
| Endometrial thickness: a predictor of implantation in ovum recipients? | Q72050998 | ||
| Abnormal endothelial cell function of resistance arteries from women with preeclampsia | Q72077460 | ||
| Expression of vascular endothelial growth factor and its receptors in the human corpus luteum during the menstrual cycle and in early pregnancy | Q73148530 | ||
| Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy | Q73788745 | ||
| Systemic administration of phosphodiesterase V inhibitor, sildenafil citrate, for attenuation of cerebral vasospasm after experimental subarachnoid hemorrhage | Q79401494 | ||
| Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsia | Q81508545 | ||
| Sildenafil citrate protects skeletal muscle of ischemia-reperfusion injury: immunohistochemical study in rat model | Q86561108 | ||
| P433 | issue | 6 | |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 718-724 | |
| P577 | publication date | 2014-11-26 | |
| P1433 | published in | Reproductive Sciences | Q7314305 |
| P1476 | title | Sildenafil Prevents Apoptosis of Human First-Trimester Trophoblast Cells Exposed to Oxidative Stress: Possible Role for Nitric Oxide Activation of 3',5'-cyclic Guanosine Monophosphate Signaling | |
| P478 | volume | 22 |
| Q58803671 | Rosiglitazone augments antioxidant response in the human trophoblast and prevents apoptosis†| cites work | P2860 |
Search more.